Journal of Ophthalmology Research & Therapeutics

Aims of the Journal

The Journal of Ophthalmology Research & Therapeutics (JORT) aims to publish original, innovative, and clinically significant research that advances scientific understanding and therapeutic development in ophthalmology and vision sciences. The journal seeks to provide an international platform for ophthalmologists, clinicians, researchers, surgeons, and healthcare professionals to exchange scientific discoveries, clinical experiences, and emerging treatment strategies related to ocular diseases and visual healthcare. JORT encourages interdisciplinary research that improves the prevention, diagnosis, treatment, and rehabilitation of eye disorders through evidence-based clinical and translational approaches. The journal supports studies in retinal diseases, glaucoma, cataract surgery, corneal disorders, refractive therapies, pediatric ophthalmology, ocular pharmacology, neuro-ophthalmology, and advanced diagnostic technologies. It also promotes innovative research related to artificial intelligence in ophthalmology, digital healthcare systems, teleophthalmology, regenerative medicine, wearable eye technologies, and personalized ophthalmic care. Through rigorous peer review and ethical publishing standards, JORT aims to maintain scientific excellence and encourage meaningful global collaboration among ophthalmic researchers and healthcare experts. The journal aspires to contribute to the advancement of modern eye care and the development of effective therapeutic solutions that improve visual health and quality of life worldwide.

Scope of the Journal

The journal welcomes original research articles, review articles, short communications, and case reports covering but not limited to the following topics:

• Retinal Diseases
• Glaucoma
• Corneal Disorders
• Cataract Surgery
• Refractive Surgery
• Pediatric Ophthalmology
• Neuro-Ophthalmology
• Ocular Oncology

Article Types Accepted

• Original Research Articles
• Review Articles
• Systematic Reviews & Meta-Analyses
• Case Reports & Case Series
• Short Communications
• Letters to the Editor
• Editorials

Open Access Policy

This journal is fully open access. All articles are freely available online immediately upon publication. Authors retain copyright of their work under a Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.